Trichofolliculoma is a benign skin tumor which is typically found on the face, scalp, and neck. It is a common skin condition that affects both men and women, although it is more commonly seen in women. Trichofolliculoma is characterized by a single, firm, dome-shaped bump with a central pore from which hairs emerge. It is usually painless and is not associated with any other medical conditions. In this article, we will take a closer look at the causes and treatment options for trichofolliculoma.
Trichofolliculoma is a benign skin tumor which is typically found on the face, scalp, and neck. It is a common skin condition that affects both men and women, although it is more commonly seen in women. Trichofolliculoma is characterized by a single, firm, dome-shaped bump with a central pore from which hairs emerge. It is usually painless and is not associated with any other medical conditions.
The exact cause of trichofolliculoma is unknown, but it is believed to be related to an abnormal hair follicle. The abnormal hair follicle is thought to be caused by a combination of genetic and environmental factors. It is believed that the abnormal hair follicle is caused by a mutation in the gene that controls the growth and development of hair follicles. This mutation causes the hair follicle to become enlarged and develop a central pore from which hairs emerge.
Trichofolliculoma is typically diagnosed by a physical exam. The doctor will examine the skin for the characteristic dome-shaped bump with a central pore from which hairs emerge. The doctor may also order additional tests such as a biopsy to confirm the diagnosis.
The treatment for trichofolliculoma typically involves surgical removal of the tumor. The procedure is usually done under local anesthesia and is usually successful in removing the entire tumor. In some cases, the tumor may recur and require additional surgery. In some cases, the doctor may recommend a topical cream or ointment to reduce the size of the tumor. These creams and ointments typically contain retinoids or corticosteroids, which are medications that can reduce inflammation and shrink the tumor. In rare cases, the doctor may recommend radiation therapy to shrink the tumor. This is usually done if the tumor is large or if it is not responding to other treatments.
Trichofolliculoma is a benign skin tumor which is typically found on the face, scalp, and neck. It is a common skin condition that affects both men and women, although it is more commonly seen in women. The exact cause of trichofolliculoma is unknown, but it is believed to be related to an abnormal hair follicle. Trichofolliculoma is typically diagnosed by a physical exam and is usually treated with surgical removal of the tumor. In some cases, topical creams or ointments may be used to reduce the size of the tumor or radiation therapy may be recommended.
1.
Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?
2.
'Sugar' signatures help identify and classify pancreatic cancer cell subtypes
3.
Dual imaging capsule captures 3D tissue and blood vessel changes for early esophageal cancer diagnosis
4.
New tumor therapy approach reduces costs and side effects while increasing accessibility
5.
AI could help improve early detection of interval breast cancers
1.
Unlocking the Secrets of Oral Cancer Staging: A New Approach to Early Detection
2.
Exploring Digital Cognitive Stimulation for Elderly Breast Cancer Patients
3.
Subarachnoid Hemorrhage: Emerging Insights into Pathophysiology and Future Management
4.
Blastic Plasmacytoid Dendritic Cell Neoplasm and the Dawn of AI-powered Diagnostics
5.
Treating Oral Fibromas: Options and Guidelines for a Healthier Mouth
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Complexities of Ph Negative ALL - Part VIII
2.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases - Part II
3.
Understanding Early Relapse in B-cell ALL: Rates, Risks, and Common Sites
4.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part III
5.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation